NASDAQ: ARCTArcturus Therapeutics Holdings Inc Stock Ownership - Who owns Arcturus Therapeutics Holdings?
Insider buying vs selling
Have Arcturus Therapeutics Holdings Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when ARCT insiders and whales buy or sell their stock.
ARCT Shareholders
What type of owners hold Arcturus Therapeutics Holdings Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Joseph E. Payne | 5.21% | 1,480,097 | $19.29M | Insider |
| Ultragenyx Pharmaceutical Inc | 4.93% | 1,400,000 | $18.24M | Insider |
| Pad Chivukula | 1.53% | 435,334 | $5.67M | Insider |
| Andy Sassine | 0.78% | 221,764 | $2.89M | Insider |
| Peter C. Farrell | 0.35% | 98,696 | $1.29M | Insider |
| Magda Marquet | 0.10% | 28,073 | $365.79k | Insider |
| James F. Barlow | 0.05% | 13,131 | $171.10k | Insider |
| Fedher | 0.01% | 3,304 | $43.05k | Institution |
| Federated Hermes Inc | 0.01% | 3,303 | $43.04k | Institution |
| Jing L. Marantz | 0.01% | 3,131 | $40.80k | Insider |
ARCT vs Biotech Stocks
Arcturus Therapeutics Holdings Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.